
What MCOs should know about insurers’ plans for the marketplace exchanges in 2018.

What MCOs should know about insurers’ plans for the marketplace exchanges in 2018.

What are the next steps for the bill, and how likely is it that it will become law? Here’s are four things MCOs should know.

Our policy analyst explains why he believes single payer Medicare-for-all is a pipe dream.

A Willis Towers Watson survey finds that employers see enhancing the employee experience in healthcare as key to boosting health engagement.

Here are four things MCOs should know about a new study focusing on young patients with diabetes.

A Gallup-Healthways poll shows it will be important to monitor the uninsured trends in the coming months as the ACA hangs in the balance.

Our policy analyst explains the concept of invisible high-risk pools, and explains how they might affect health reform.

To date, the CDC reports 5,234 Zika virus disease cases in the United States and 36,526 cases in U.S. territories. Here’s where we are in the vaccine development process.

What exactly did House representatives on both sides of the aisle dislike about the AHCA? Here’s a look at what MCOs should know.

From public furor over price hikes to the loss of patent protections for blockbuster drugs, big changes are afoot in the pharmaceutical marketplace. Read more.

Weighing the ethics of approving expensive cancer drugs for patients facing terminal disease is a multifaceted endeavor. Here are some recommendations.

Medical marijuana’s therapeutic evidence base remains nascent and controversial but the regulatory landscape is evolving rapidly.

On March 10, the White House announced that President Donald Trump selected Scott Gottlieb, MD, who has worked for FDA in the past, as his choice to head the FDA. Here are five things managed healthcare executives should know about the pick.

Our policy analyst weighs in on a new drug industry PR campaign that attempts to shift the blame for high drug costs.

With ACA repeal and replace on the horizon, digital healthcare solutions will surely be affected.

What should managed care executives know about the GOP ACA replacement plan? Find out.

ACA repeal or replacement must focus on how to preserve mental health services and pharmacy access.

Industry leaders share their go-to strategies.

Seven ways health execs can prepare for the future.

While Trump has touted Obamacare as a “disaster,” some healthcare experts say the change could negatively impact hospitals in a variety of ways.

Health plans of the future will focus on consumers: designing products, care and services to support improved health.

New treatment indications are under investigation for the use of cannabinoid-based drugs. Are you ready?

Republicans recently unveiled their ACA replacement plan. Here’s what the experts say you need to know.

Health insurance has served different purposes over the years. It may be time to rethink today’s system.

Will Trump’s policies hamper or improve healthcare access? Experts weigh in.